131 results
424B2
CLPT
ClearPoint Neuro Inc
1 Mar 24
Prospectus for primary offering
8:00am
, litigation matters and our ability to obtain patent protection for our technologies;
Additions or departures of key personnel;
Significant lawsuits … , including patent, products liability, or stockholder litigation;
Changes in the market valuations of similar companies;
Purchases and sales of our
424B5
CLPT
ClearPoint Neuro Inc
28 Feb 24
Prospectus supplement for primary offering
4:05pm
developments relating to proprietary rights, including patents, litigation matters and our ability to obtain patent protection for our technologies … ;
Additions or departures of key personnel;
Significant lawsuits, including patent, products liability, or stockholder litigation;
Changes
8-K
EX-10
d2crron4x 4fss9o6
14 Feb 22
Results of Operations and Financial Condition
4:05pm
8-K
EX-10.2
kr6gh4
28 Jun 21
Statement of Policy
8:30am
424B5
kgmw02m
19 Feb 21
Prospectus supplement for primary offering
4:57pm
424B5
79h2yhj46gp2a
18 Feb 21
Prospectus supplement for primary offering
4:35pm
8-K
EX-99
w0441oj5
14 Feb 20
ClearPoint Neuro, Inc. Announces 2020 Revenue Outlook Ahead of Nasdaq Investor Presentation Today
9:01am
8-K
EX-10
ndll5 wr1mr9
29 Jan 20
MRI Interventions, Inc. Closes $17.5 Million Strategic Investment from PTC Therapeutics, Inc. and Petrichor Healthcare Capital Management
4:42pm